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Background. The increase of the optic nerve sheath diameter (ONSD) is a reliable, noninvasive sonographic marker of intracranial
hypertension. Aim of the study was to demonstrate the efficacy of ONSD evaluation, when monitoring neurocritical patients,
to early identify malignant intracranial hypertension in patients with brain death (BD). Methods. Data from ultrasound ONSD
evaluation have been retrospectively analyzed in 21 sedated critical patients with neurological diseases who, during their clinical
course, developed BD. 31 nonneurological controls were used for standard ONSD reference. Results. Patients with neurological
diseases, before BD, showed higher ONSD values than control group (CTRL: RT 0.45 ± 0.03 cm; LT 0.45 ± 0.02 cm; pre-BD: RT
0.54 ± 0.02 cm; LT 0.55 ± 0.02 cm; 𝑝 < 0.000) even without intracranial hypertension, evaluated with invasive monitoring. ONSD
was further significantly markedly increased in respect to the pre-BD evaluation in neurocritical patients after BD, with mean
values above 0.7 cm (RT 0.7 ± 0.02 cm; LT 0.71 ± 0.02 cm; 𝑝 < 0.000), with a corresponding dramatic raise in intracranial pressure.
Logistic regression analysis showed a strong correlation between ONSD and ICP (𝑅 0,895, 𝑝 < 0.001). Conclusions. ONSD is a
reliable marker of intracranial hypertension, easy to be performed with a minimal training. Routine ONSD daily monitoring could
be of help in Intensive Care Units when invasive intracranial pressure monitoring is not available, to early recognize intracranial
hypertension and to suspect BD in neurocritical patients.
1. Introduction
Since the last few years, eye sonography detection of an
increased optic nerve sheath diameter (ONSD) has been
considered a reliable noninvasive indicator of intracranial
hypertension [1–14]. Intracranial pressure (ICP) is a funda-
mental parameter for monitoring the neurocritical patients
since,when it overridesmean arterial bloodpressure, cerebral
perfusion stops and BD occurs after cerebral circulatory
arrest [15]. For these reasons, authors suggest a strict ICP
monitoring, even through invasive methods, in the neuro-
logical critical patients in Intensive Care Units (ICUs) [16], to
promptly treat those who develop intracranial hypertension.
Nonetheless, the risk/benefit of invasive ICP monitoring has
to be evaluated, considering that it requires specific personnel
for the catheter insertion, maintenance, and troubleshooting,
and it has been associated with cerebral damage and infective
risks.Thus, since all these factors must be kept in mind when
deciding whether to use invasive ICP monitoring, to date
there are no sufficient evidences to suggest the routine use
of ICP invasive monitoring [16].
On the other hand, in neurocritical, sedated, andmechan-
ically ventilated patients, BD has to be recognized as soon
as possible, in order to identify the potential candidates
to be selected for organ donation, thus minimizing the
time that could lead to organs deterioration. Clinically,
BD diagnosis is suspected in case of unresponsive coma,
persistent apnea, and absence of brainstem reflexes, all signs
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that are underdiagnosed during sedation. Moreover, these
patients are usually already admitted to ICUs since days
before BD occurrence, and their clinical neurological state
is continuously clinically monitored to early detect these
signs of deterioration, being easier to be suspected when
a dramatic increase of ICP is also observed. When BD is
suspected, a clinical and instrumental diagnostic protocol is
then soon started. The diagnostic protocol, slightly different
in each country, is usually composed of a multidisciplinary
approach; beyond clinical and respiratory parameters eval-
uation, it usually includes an EEG, showing the absence of
cortical electrical activity, as well as several “ancillary tests”
(i.e., somatosensory evoked potentials and, in specific cases,
blood flow evaluation with Transcranial Doppler, cerebral
angiography, and other conventional radiological imaging)
[17]. This multidisciplinary approach is strictly conservative
and guarantees the highest sensibility and specificity for
final BD diagnosis. However, it requires different specialists
“on call,” to be ready when their cooperation is needed;
thus, the task of coordinating may be difficult in every day
ICU practice, further lengthening the times to final BD
declaration [18, 19] with the possibility of organ deterioration
in case of consent to harvest, a subject of actual social
relevance.
Ultrasound devices are nowadays widely available in
ICUs, but while Transcranial Doppler sonography for the
identification of cerebral circulatory arrest requires trained
and skilled sonographers, ONSD evaluation, to early detect
the optic nerve sheath swelling in cases of intracranial
hypertension, may be performed with minimal training and,
above all, noninvasively [20, 21].
The aim of the study was to demonstrate the efficacy
and simplicity of ONSD ultrasound evaluation in ICU in
neurocritical patients monitoring, in order to early identify
malignant intracranial hypertension in patients with BD.
2. Materials and Methods
2.1. Subjects. Neurocritical patients, admitted to ICU for
acute neurological diseases (intracerebral hemorrhage, sub-
arachnoid hemorrhage, trauma, tumor, and postanoxic
coma) from September 2015 to April 2016, were included in
this study.
Data from ultrasound ONSD evaluation have been retro-
spectively analyzed in those patients, sedated and mechan-
ically ventilated, who subsequently developed BD during
their clinical course. In all BD patients, BD was diagnosed
according to the following criteria laid down by Italian law:
(1) unresponsiveness and absence of brainstem reflexes, eval-
uated by means of a neurological examination; (2) absence
of spontaneous breathing and apnea test revealing PCO2 >
60mmHg and pH < 7.40; (3) absence of cortical electrical
activity on the EEG tracing recorded at high sensitivity
(2 𝜇V/mm), in the basal condition and under acoustic and
pain stimulation, for at least 30 minutes at the beginning and
at the end of the 6-hour evaluating protocol [19].
No other confirmatory tests (such as somatosensory
evoked potentials) were used.
Right and Left ONSDs measured daily before BD occur-
rence (pre-BD) and before the ending of BD declaration
protocol (post-BD) were obtained. In these patients, ICP
invasive monitoring was retrospectively analyzed as well.
To obtain intraobserver normal reference values, patients
without central nervous system damage or clinical signs of
intracranial hypertension were used as control group.
Patients received the best medical treatment and the
study involved usual standard monitoring measures used in
ICUs. Written informed consent was obtained from control
group patients. The study was approved by the local ethics
committee.
2.2. ONSD Ultrasound Evaluation. In both patients and
control, ONSD was evaluated with ultrasound, as already
described in literature [1–14], with a 12MHz linear ultrasound
probe with reduced acoustic power [mechanical index (MI):
0.2]. The probe was adjusted to give a suitable angle for
displaying the entry of the optic nerve into the globe and
measurement performed at the depth of 3mm behind the
ocular globe. Right and left ONSD were measured in the
transversal plane, with slight rotation of the probe to obtain
the better optic nerve visualization.
2.3. Statistical Analysis. Normality of the distributions was
assessed with the Shapiro-Wilk Normality Test; according to
the result of normality analysis, Student’s 𝑡-test or Wilcoxon
test were used to compare mean ONSD values differences.
ANOVA with post hoc analysis with Bonferroni and Scheffe´
corrections were used to determine interactions between
groups. Correlation between ONSD and ICP was assessed by
means of logistic regression analysis.
All tests were two-tailed with significance set to alpha =
0.05. Data were analyzed with SPSS software for Windows
(Version 18.0).
Based on ONSD normative values reported in the lit-
erature [11], a priori power analysis was performed by
means ofWilcoxon-Mann–Whitney tests (a priori computed
required sample size). We calculated that a total sample of 20
neurological critical patients would provide a power of 95%
to reach a statistical significance in ONSD values differences
between pre-BD and controls (𝛼-error 0.05, effect size 1.21)
and between pre-BD and post-BD as well (𝛼-error 0.05, effect
size w 1.26).
Post hoc power analysis (Wilcoxon-Mann–Whitney tests,
post hoc computed achieved power) was used to determinate
the level of statistical power achieved for statics validation.
3. Results
We retrospectively analyzed data from 21 neurocritical
patients (M/F 11/10, mean age: 54 ± 13.5), sedated and
mechanically ventilated, who subsequently developed BD
during their clinical course. Out of these, two were submitted
to decompressive craniectomy.
As control group, we also enrolled 31 patients (M/F 14/17,
mean age: 56.3±10.3) without central nervous systemdamage
or clinical signs of intracranial hypertension.
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Figure 1: Box plot with interquartile range (IQR) distribution of ONSD values in patients and controls (a), with an example of two subsequent
ONSD measurements in a patient in the pre-BD phase (b) and after BD occurrence (c). Marks indicate the optic nerve sheath, green line
indicates the diameter, and yellow line indicates the measurement performed at the depth 0.3 cm behind the ocular globe.
Table 1: ONSDmean values (cm ± SD) in controls (CTRL), in neurological patients before brain death (pre-BD), after brain death (after BD)
and in the 2 patients with brain death and decompressive craniectomy. Intracranial pressure values are also reported (ICP, mmHg).
CTRL
(𝑛 = 31)
Pre-BD
(𝑛 = 21)
ICP After BD
(𝑛 = 19)
ICP BD + craniectomy
(𝑛 = 2)
Right 0.45 ± 0.03 0.54 ± 0.02 7 ± 2 0.7 ± 0.02 38 ± 9.4 0.56 ± 0.03
Left 0.45 ± 0.02 0.55 ± 0.02 0.71 ± 0.02 0.58 ± 0.04
In the control group, mean ONSD was 0.45 ± 0.03 cm
for right side and 0.45 ± 0.02 cm for left side. No differ-
ences for ONSD side were observed. In the neurological
patients, sedated and mechanically ventilated, who subse-
quently developed BD, ONSD values before BD occurrence
were slightly significantly higher than in the control group
(pre-BD: RT 0.54 ± 0.02 cm; LT 0.55 ± 0.02 cm; CNTR: RT
0.45±0.03 cm; LT 0.45±0.02 cm; 𝑝 < 0.000). At this stage, as
expected, intracranial invasive pressuremeasurement in neu-
rocritical patients was within normal values (7 ± 2mmHg).
After BD occurrence, ONSD was further significantly
markedly increased, greater than 0.7 cm (RT 0.7 ± 0.02 cm;
LT 0.71 ± 0.02 cm; 𝑝 < 0.000) in respect to the pre-BD phase,
except for the 2 patients who had submitted to decompressive
craniectomy, in whom ONSD was substantially unchanged
(before BD: RT 0.56 ± 0.01 cm; LT 0.57 ± 0.01 cm. After
BD: RT 0.56 ± 0.03; LT 0.58 ± 0.04 cm). The increase of
ONSD was constantly correlated with elevated values of
ICP (38 ± 9mmHg) in the patients with BD who were not
submitted to decompressive surgery. Figure 1 shows box plot
with interquartile range (IQR) distribution ofONSDvalues in
patients and controls (a), with an example of two subsequent
ONSD measurements in a patient in the pre-BD phase (b)
and after BD occurrence (c). Grouped and individual data are
reported in Tables 1 and 2, respectively.
ANOVA showed a significant difference between the
three groups (CTRL, pre-BD, and post-BD. RT ONSD: 𝐹 =
477.2; 𝑝 < 0.000. LT ONSD: 𝐹 = 610.4; 𝑝 < 0.000) con-
firming the differences observedwithin the groups atmultiple
comparisons after Bonferroni and Scheffe´ corrections.
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Table 2: ONSD results, right (RT, cm) and left (LT, cm), and intracranial pressure (ICP, mmHg) in controls and neurological patients with
brain death.
Controls Neurological patients with outcome in brain death
Before brain death After brain death
RT LT Diagnosis ICP RT LT ICP RT LT
Pt 1 0.48 0.47 ICH 8 0.54 0.53 45 0.71 0.72
Pt 2 0.49 0.49 ICH 7 0.52 0.55 48 0.68 0.69
Pt 3 0.44 0.43 Trauma 9 0.56 0.57 34 0.7 0.71
Pt 4 0.45 0.46 ICH 9 0.51 0.52 38 0.72 0.73
Pt 5 0.41 0.42 Trauma 8 0.58 0.58 30 0.71 0.74
Pt 6 0.48 0.47 SAH 6 0.57 0.57 21 0.72 0.71
Pt 7 0.48 0.47 Trauma 5 0.58 0.57 25 0.69 0.64
Pt 8 0.45 0.46 ICH 8 0.52 0.52 28 0.71 0.72
Pt 9 0.46 0.45 ICH 9 0.53 0.52 35 0.71 0.72
Pt 10 0.43 0.44 SAH 7 0.5 0.51 40 0.71 0.73
Pt 11 0.48 0.47 Tumor 6 0.57 0.57 45 0.68 0.71
Pt 12 0.48 0.47 Tumor 8 0.58 0.58 50 0.74 0.73
Pt 13 0.47 0.46 ICH 9 0.52 0.53 28 0.69 0.69
Pt 14 0.46 0.47 ICH 8 0.53 0.52 30 0.72 0.74
Pt 15 0.42 0.43 Trauma 4 0.54 0.57 35 0.68 0.69
Pt 16 0.44 0.45 Trauma 3 0.53 0.55 50 0.68 0.71
Pt 17 0.46 0.47 ICH 3 0.5 0.53 54 0.74 0.72
Pt 18 0.47 0.48 Postanoxic 9 0.58 0.57 41 0.75 0.74
Pt 19 0.44 0.45 Postanoxic 8 0.56 0.55 45 0.72 0.71
Pt 20 0.48 0.49
Pt 21 0.49 0.48 Trauma + DC / 0.57 0.58 / 0.59 0.61
Pt 22 0.48 0.47 ICH + DC / 0.55 0.56 / 0.54 0.55
Pt 23 0.42 0.43
Pt 24 0.42 0.43
Pt 25 0.49 0.48
Pt 26 0.38 0.37
Pt 27 0.42 0.44
Pt 28 0.39 0.4
Pt 29 0.49 0.48
Pt 30 0.47 0.45
Pt 31 0.49 0.47
ICH: intracerebral hemorrhage; SAE: subarachnoid hemorrhage; DC: decompressive craniectomy.
Logistic regression analysis showed a strong correlation
between ONSD and ICP (𝑅 0,895, 𝑝 < 0.001). Correlation
graph was reported in Figure 2.
Post hoc power analysis (Wilcoxon-Mann–Whitney tests,
post hoc computed achieved power) showed that a sample
size of 21 neurological critical patients and 31 controls pro-
vided sufficient power for statics validation (pre-BD versus
control: power 1; 𝛼 err 0.05; effect size w 4.03; pre-BD versus
post-BD: power 1; 𝛼 err 0.05; effect size w 4.91).
4. Discussion
From a pathophysiological point of view, BD is caused by
an acute central nervous system damage, which may be
related to a direct “primary” lesion, such as intracerebral
bleeding, severe cerebral concussion, and brain tumors, or to
indirect “secondary” causes such a diffuse prolonged cerebral
hypoxia following cardiopulmonary resuscitation. The final
consequence of all these conditions is that they determine a
dramatic brain edema and cerebral parenchyma swellingwith
uncontrollable intracranial hypertension, leading to cerebral
circulatory arrest and consequent cessation of brain electrical
activity [15].
Several clinical studies described the increase of ONSD
evaluated with ultrasound as a reliable noninvasive method
to detect intracranial hypertension in neurosurgery and ICUs
[1–14]. As a matter of fact, the optic nerve sheath is directly
connected with the subarachnoid space, and, differently from
the skull that it is inextensible, the intraorbital subarachnoid
meningeal prolongation is then free of swelling with the
pressure increase in the cerebrospinal fluid. Historically,
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Figure 2: Logistic regression analysis (ONSD versus ICP). See the
text for the details.
the sign of the papilledema is a typical expression of this
phenomenon.
The evaluation of the ONSD with ultrasound seems then
to be a reliable indicator of intracranial hypertension, with
high intra- and interobserver reliability (with up to 2 decimals
of centimeter) and with a whole range from 0.43 to 0.76mm
[2]. A growth of the sheath diameter from 0.4 to 0.45 cm is
detectable among first 4 years of life [10, 22], while normal
adults have mean ONSD values of about 0.5 cm [23]. In
neurological patients with stroke, intracerebral or subarach-
noid hemorrhage, wider values, of about 0.59 to 0.63 cm,
are reported [24]; otherwise, there are no reported values
lower than 0.58 cm when ICP is detected over 20mmHg
[3]. Only one study reports an increase of ONSD of up to
0.72 cm in patients with BD, butwithout available data on ICP
monitoring [7].
Our data are in line with all these findings, confirming the
ONSD values in the control group, and showing a slight wider
optic nerve sheath diameter in neurological critical patients,
ranging from 0.50 to 0.58 cm, and with normal values of ICP
(i.e., lower than 10mmHg).
The main finding of our study is that we have observed
the widest ONSD values occurring after BD, from 0.68 to
0.75 cm, and with ICP values from 28 to 54mmHg. Logistic
regression analysis confirmed this strong correlation between
increased ONSD and raise in ICP, with mean OSND values
above 0,68 cm in BD patients (Figure 2, patients lying on the
upper side of the graph) reflecting a raise in intracerebral
pressure higher than the mean arterial blood pressure. Such
optic nerve sheath swelling could then be considered the
expression of the final, extreme compensative strategy to
the massive brain swelling in the inextensible skull, and
correlated with the demonstration of the malignant ICP
increase at the time of BD diagnosis.
Moreover, the confirmation that intracranial pressure
fatally affects ONSD is indirectly demonstrated by the lack of
ONSD increase in our patients with decompressive craniec-
tomy; the lack of ONSD swelling in these patients could be
explained by incapacity of the intracranial pressure to reach
such a dramatic increase as to induce cerebral circulatory
arrest or to determine optic sheath swelling over 0.7 cm.
In other words, since craniectomy prevents malignant ICP
increase, ONSD normal values in the two craniectomies are
actually the proof of concept that OSND measurement is
strongly related to ICP.
A limitation of the present study is a missing control
group consisting in ICU patients who finally did not develop
BD. Nonetheless, in patients who do not develop BD, no
suspicion of fatal intracranial hypertension leading to circu-
latory arrest, brain swelling, and increase of ONSD may be
hypothesized. As a matter of fact, we compared ONSD in
the same patient before and after BD developing; given the
small sample of patients, this otherwise helped to avoid any
intersubject factors known to influence ONSDmeasurement,
thereby resulting in a more reliable representation of how
ONSD values change according to malignant intracranial
hypertension.
The importance of our findings that represent our final
take-homemessage is not the role of a single ONSDmeasure-
ment or the absolute value of ONSD for BD diagnosis. It is
indeed pleonastic that BD diagnosis in ICU is not made upon
the only evaluation of ONSD. In fact, even though ONSD
is significantly greater in subjects with BD, quantification of
ONSD cannot discriminate BD subjects from comatose ones
with raised ICP with 100% certainty [25].
Otherwise, it seems noteworthy to underline that ONSD
ultrasound evaluation could be of strong help during clinical
monitoring to early detect the cases with raised intracranial
pressure and to suspect clinical deterioration, when dramatic
ONSD increase, over 0.7 cm, is observed over time. This
is particularly true in neurocritical patients sedated and
mechanically ventilated or when invasive ICP monitoring is
not available so that, in these patients, further investigations
for BDdiagnosis can be startedwithmore consistent data and
avoiding useless evaluations.
Moreover, ONSD evaluation with ultrasound can be
performed with short training from almost every medical
and paramedical personnel. Thus, ONSD appears as an easy
and noninvasive diagnostic tool to early identify malignant
intracranial hypertension during anesthesiological routine
daily follow-up of critical patients.
5. Conclusion
ONSD evaluation with ultrasound may be easily performed,
with minimal training, also by nonspecific neurosonologist.
ONSD routine monitoring may be of help in Intensive Care
Units, to early detect patientswith raised intracranial pressure
when invasive ICP monitoring is not available; it also allows
to suspect BDwhenONSD is rapidly increased over time and
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over 0.7 cm, especially in those neurocritical patients, sedated
and mechanically ventilated, who develop signs of cerebral
deterioration.
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